January / February 2012
Warning: Isentress Rash
by Laura Whitehorn
The FDA has released new, critical information about the integrase inhibitor Isentress (raltegravir). In a nutshell: If you develop a rash after you start taking this HIV med, call your health care provider immediately. Click here to check out the Isentress drug page for details.
Search: Food and Drug Administration, FDA, Isentress, integrase inhibitor, rash
Scroll down to comment on this story.